As much as OTC companies utilize the R/S, it would not be necessary for Suti to go this route. They decided recently to increase their A/S for financing which is the only option they had if they want to keep moving forward as a company. They cannot escape the fact that they have debt, just like every other start up company that ever existed. What should Suti do in this situation? Should they give up and embrace failure? Or will they continue on as planned and make strides to develop the company for future success. The simple fact that Suti has signed contracts with NYU and Arizona U. in the past few months is proof enough that they are not ready to quit. Suti's only options were to sit in debt without money and wait for success, or to make some tough decisions to aquire financing. The reason an R/S is unlikely is due to the products Suti is developing. Many of the companies that I have seen go through an R/S are trying to survive in a very competitive market, such as clothes or internet service. They do an R/S in an attempt to upgrade exchanges to gain attention from larger investors. Suti should be well aware that the university breakthroughs that they are developing will not need any help getting attention. An R/S by Suti would be very unnecessary and detrimental to investor confidence. IMO Suti has been making the approriate steps to grow the company. It may not be an easy ride, but we will get there. IMHO. GLTA.
